Customer Service: 952-500-7200 Technical Support & Order Status

Tissue Transglutaminase (tTG; expressed in Baculovirus/Sf9)

Tissue transglutaminase (tTG; syn. TGase-2) is an ubiquitously expressed enzyme, which exerts protein deamidation and transamidation activity leading to the creation of neo-epitopes and the cross-linking of proteins, respectively. DIARECT™s tTG has been sequence modified to eliminate this cross-linking activity and to prevent covalent aggregates of tTG with host cell proteins. DIARECT™ antigens are for further manufacturing or research use only.

Origin
Recombinant. Expressed by recombinant baculovirus (Autographa californica multiple nuclear polyhedrosis virus; AcMNPV) infection of Spodoptera frugiperda Sf9 insect cells.
Biochemical Test
SDS-PAGE (purity> 95%); Western blot with i: anti-tTG autoantibody positive sample; ii: monoclonal anti­His-tag antibody.
Calculated Molecular Weight
78 kDa
Calculated Isoelectric Point
pH 5.3
Coating Concentration
0.6-1.4 µg/ml (depending on the type of ELISA plate and coating buffer). Suitable for labeling of functional groups. Remark: very diverse coating protocols exist in the literature; DIARECT recommends extensive testing in assay development.  

A152


Filter
Option Quantity Unit Purchase
TISSUE TRANSGLUTAMINASE
A15200
 50 µg
$140.00/EA
In Stock
TISSUE TRANSGLUTAMINASE
A15201
 1.0 mg
$1,560.00/EA
In Stock
With Selected Items:

Contact Us

Our team has the expertise and commitment to provide best-in-class solutions to meet your IVD needs.

Technical Support
& Order Status

Customer Service
952-500-7200